Money
Briefing: Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk
Strategic angle: Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but prescription stockpiles are limited.
editorial-staff
1 min read
Updated 26 days ago
The Strait of Hormuz is a critical transit route for pharmaceuticals, particularly for generic drugs produced in India, which account for half of the U.S. supply.
Recent geopolitical tensions in the region have prompted supply chain analysts to assess the potential impacts on drug availability and distribution.
While supply chains are typically designed to handle emergencies, current stockpiles of prescription medications are reported to be limited, raising concerns about future accessibility.